PER percheron therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-17

  1. 1,472 Posts.
    lightbulb Created with Sketch. 658
    Its not a good post, its misleading and opinion only. He has no idea what the FDA will or wont approve and when. The company have previously indicated a phase 3 may be necessary.
    He has no idea re the level of interest or at which stage any of it might be at - all assumption only and remember his assumptions are generally very wrong...
    In terms of pharma's on the sidelines, why wouldn't they be...Sidelines could mean anything. Its clear there is no interest right now regardless of that the company says (refer crap raise). Pharma's will know this mob care about low priced options for themselves and happy to let brokers get their way dishing out way more dilution than required at a discount that shows they cannot negotiate or couldnt back themselves in...
    Proceed with caution and dont get blinded by the shiny thing JG keeps pointing to in the distance...
    GLAH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $4.742K 474.2K

Buyers (Bids)

No. Vol. Price($)
1 4082895 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3153423 5
View Market Depth
Last trade - 10.39am 24/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.